Akanda (AKAN) Receivables - Other (2022 - 2025)

Akanda (AKAN) recorded quarterly Receivables - Other of $368172.0 in Q4 2024, up 310.83% quarter-over-quarter from $89617.0 in Q4 2023, and up 310.83% on a YoY basis from $89617.0 in Q1 2024.

Akanda (AKAN) Receivables - Other (2022 - 2025) Analysis & Trends

Akanda's Receivables - Other history runs 3 years deep, the most recent figure standing at $368172.0 for Q4 2024.

  • In Q4 2024, Receivables - Other rose 310.83% year-over-year to $368172.0; the TTM figure through Dec 2024 stood at $368172.0 (up 310.83% YoY), while the FY2024 annual figure was $368172.0, up 310.83% from the prior year.
  • Receivables - Other was $368172.0 for Q4 2024 at Akanda, up from $89617.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $424118.0 in Q4 2022 to a low of $89617.0 in Q4 2023.
  • Historically, Receivables - Other has averaged $293969.0 across 3 years, with a median of $368172.0 in 2024.
  • The sharpest annual moves came in 2023 and 2024: Receivables - Other tumbled 78.87% in 2023, then jumped 310.83% in 2024.
  • A 3-year view of Receivables - Other shows it stood at $424118.0 in 2022, then sank by 78.87% to $89617.0 in 2023, then surged by 310.83% to $368172.0 in 2024.
  • The last three Receivables - Other figures came in at $368172.0 (Q4 2024), $89617.0 (Q4 2023), and $424118.0 (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Akanda 826.99 Mn 824.46 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1,031.00
Dec 31, 2025 1,031.00
Dec 31, 2024 368,172.00
Dec 31, 2024 368,172.00
Dec 31, 2023 89,617.00
Dec 31, 2023 89,617.00
Dec 31, 2022 424,118.00
Dec 31, 2022 424,118.00